This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Contipro A.s.. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Leos Hromek: Innovator in Hyaluronic Acid Conjugates
Introduction
Leos Hromek is a notable inventor based in Medlesice, Czech Republic. He has made significant contributions to the field of biochemistry, particularly in the development of innovative conjugates of hyaluronic acid. His work has implications for cancer treatment, showcasing the potential of his inventions in medical applications.
Latest Patents
Leos Hromek holds a patent for "Conjugates of oligomer of hyaluronic acid or of a salt thereof, method of preparation thereof and use thereof." This invention relates to conjugates of hyaluronic acid oligomer, which are designed to release oligomers in their native form. The prepared systems have demonstrated enhanced biological activity against selected lines of cancer cells, marking a significant advancement in therapeutic strategies.
Career Highlights
Hromek's career is marked by his dedication to research and innovation in the field of biochemistry. His work at Contipro A.S. has allowed him to explore the potential of hyaluronic acid in various applications, particularly in medicine. His innovative approach has led to the development of new methods and products that could benefit patients and healthcare providers alike.
Collaborations
Leos Hromek has collaborated with notable colleagues, including Petra Sedova and Vladimir Velebny. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the impact of their research.
Conclusion
Leos Hromek's contributions to the field of biochemistry, particularly through his patent on hyaluronic acid conjugates, highlight his role as an innovator. His work not only advances scientific knowledge but also holds promise for future medical applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile